Listed

Nuo Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2018

Filed with the SEC on Apr 16, 2019 and accepted by EDGAR at Apr 16, 2019, 17:27 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2018-01-01 to 2018-12-31$1.4mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue12 months2018-01-01 to 2018-12-31$163.0kus-gaap:CostOfRevenue
Gross profit12 months2018-01-01 to 2018-12-31$1.2mus-gaap:GrossProfit
Research and development12 months2018-01-01 to 2018-12-31$576.2kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2018-01-01 to 2018-12-31−$1.5mus-gaap:OperatingIncomeLoss
Net income12 months2018-01-01 to 2018-12-31−$1.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2018-01-01 to 2018-12-31−$0.07us-gaap:EarningsPerShareDiluted
Basic EPS12 months2018-01-01 to 2018-12-31−$0.07us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2018-01-01 to 2018-12-3123,278,564 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2018-01-01 to 2018-12-31−$874.4kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2018-12-31$636.9kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$866.7kus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$975.5kus-gaap:Assets
Current liabilitiesAt period end2018-12-31$1.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-12-31$1.1mus-gaap:Liabilities
Shareholders' equityAt period end2018-12-31−$82.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-19-007338. Last ingested by Listed: Nov 14, 2026, 23:44 ET. Listed shows no prices and gives no investment advice.